Access cutting-edge large b-cell lymphoma treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access large b-cell lymphoma specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related large b-cell lymphoma treatment provided free
The goal of this clinical study is to compare the study drug, axicabtagene ciloleucel, versus standard of care (SOC) in first-line therapy in participants with high-risk large B-cell lymphoma.
Sponsor: Kite, A Gilead Company
Check if you qualify for this large b-cell lymphoma clinical trial in Palo Alto, CA
If you're searching for large b-cell lymphoma treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced large b-cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.